NCT03384329View on ClinicalTrials.gov

Efficacy of Resveratrol in Depression

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 4, 2018

Primary Completion Date

August 27, 2019

Study Completion Date

September 18, 2019

Conditions
Depression
Interventions
DRUG

Resveratrol Pill

Resveratrol 500 mg

DRUG

Placebos

Placebo Pills

Trial Locations (1)

630117

Lyubomir I. Aftanas, Novosibirsk

All Listed Sponsors
collaborator

Russian Science Foundation

OTHER

lead

Russian Academy of Medical Sciences

OTHER

NCT03384329 - Efficacy of Resveratrol in Depression | Biotech Hunter | Biotech Hunter